Skip to content

Insider · CIK 0001889279

Damon DeSantis

director

Files at INBP (INTEGRATED BIOPHARMA INC), CELH (Celsius Holdings, Inc.). First filing Sep 15, 2026, latest Sep 15, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$1.0M bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

CELH: Celsius Holdings, Inc.

CELHOct 9, 2026 · close 28.58

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
55Moderate
CELHbuy 3
Celsius Holdings, Inc.
$1.0M
36,000 shares
+1%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 14, 2026CELH
Celsius Holdings, Inc.
POpen-market purchase
Common Stock, $0.001 par value per share
+20,000$27.65$553k2,712,18727 d ago
Sep 15, 2026CELH
Celsius Holdings, Inc.
POpen-market purchase
Common Stock, $0.001 par value per share
+16,000$27.95$447k2,728,18727 d ago
Jun 18, 2025INBP
INTEGRATED BIOPHARMA INC
AGrant or award
Stock Option (right to buy)derivative
+50,000$0.00$050,000Jun 20, 2025
Mar 1, 2025CELH
Celsius Holdings, Inc.
AGrant or award
Common Stock, $0.001 par value per share
+4,865$0.00$02,689,576Mar 4, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Damon DeSantis: insider trades and track record | InsiderTell